Trials / Completed
CompletedNCT01784133
A Twelve Week Safety and Efficacy Study in Rosacea
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Maruho Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate th safety and efficacy of one-daily topical application of CLS001 low, mid and high dose compared to vehicle gel in subjects with papulopustular rosacea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | omiganan | |
| DRUG | placebo |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2014-03-01
- First posted
- 2013-02-05
- Last updated
- 2015-05-20
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01784133. Inclusion in this directory is not an endorsement.